FDA Inspection 1254526 — I 3 PHARMACEUTICALS, LLC
The FDA completed an inspection of I 3 PHARMACEUTICALS, LLC on November 22, 2024 in Warminster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 22, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warminster, PA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)